共 50 条
- [2] INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH CHOROIDAL NEVUS [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (01): : 60 - 67
- [3] Intravitreal ranibizumab for choroidal neovascularization associated with circumscribed choroidal haemangioma [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 (09): : 916 - 918
- [4] INTRAVITREAL BEVACIZUMAB AS TREATMENT FOR EXTRAFOVEAL CHOROIDAL NEOVASCULARIZATION IN CHOROIDAL NEVUS [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 : 63 - 64
- [5] INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF INFLAMMATORY CHOROIDAL NEOVASCULARIZATION [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (05): : 871 - 879
- [7] Choroidal neovascularization associated with Choroidal Nevus [J]. OPHTHALMOLOGE, 2019, 116 (01): : 2 - 2
- [8] Intravitreal ranibizumab (Lucentis®) for the treatment of myopic choroidal neovascularization [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2009, 247
- [9] Intravitreal injections of ranibizumab in treatment of idiopathic choroidal neovascularization [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 3780 - 3784